ESC 365 - Continuous vs. interrupted anticoagulation for atrial fibrillation ablation patients - what do the data tell us?

ESC Premium Access

Continuous vs. interrupted anticoagulation for atrial fibrillation ablation patients - what do the data tell us?

Session: Atrial fibrillation ablation: stroke and bleeding

Topic: Pathophysiology and Mechanisms

Speaker: Professor L. Di Biase (The Bronx, US)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Luigi Di Biase

Albert Einstein Medical Center, The Bronx (United States of America)

30 presentations

1 follower

3 more presentations in this session

Silent brain lesions and clinically relevant bleeds - the next frontiers for making atrial fibrillation ablation safer.

Speaker: Professor L. Mont (Barcelona, ES)

Who should be considered for left atrial appendage occlusion in the era of direct anticoagulants?

Speaker: Professor M. Glikson (Jerusalem, IL)

The key question: can anticoagulation be abandoned after catheter ablation of atrial fibrillation?

Speaker: Doctor A. Verma (Montreal, CA)

Access the full session

Atrial fibrillation ablation: stroke and bleeding

Speakers: Professor L. Di Biase, Professor L. Mont, Professor M. Glikson, Doctor A. Verma

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources